Hikma Pharmaceutical | HIK - El Costo De Ventas





El Costo De Ventas Cambio Fecha
Almirall EUR 199.26M 7.76M 2026-06
argenx SE USD 145M 24M 2026-06
AstraZeneca USD 2.52B 2.73B 2026-06
Autolus Therapeutics Ltd USD 24.57M 762K 2026-03
Bayer EUR 4.54B 692M 2026-06
Fresenius EUR 4.4B 111M 2026-06
Genmab DKK 84M 19M 2026-06
GlaxoSmithKline GBP 2.07B 192M 2026-06
GRIFOLS EUR 1.17B 90M 2026-06
Hikma Pharmaceutical USD 959M 492.5M 2025-12
Lakefront Biotherapeutics EUR 9.14M 4.35M 2026-06
Lonza CHF 2.28B 189M 2025-06
Merck EUR 2.27B 199M 2026-06
Orion EUR 181.7M 18M 2026-06
Recordati EUR 199.38M 3.22M 2026-06
Roche Holding CHF 7.85B 630M 2026-06
Sanofi EUR 3.02B 656M 2026-06
UCB EUR 1.07B 146M 2025-12